The role of interventional oncology in the treatment of colorectal cancer liver metastases

This item is provided by the institution :
Hellenic Society of Gastroenterology   

Repository :
Annals of Gastroenterology   

see the original item page
in the repository's web site and access all digital files if the item*



The role of interventional oncology in the treatment of colorectal cancer liver metastases (EN)

Palialexis, Kostantinos
Tsitskari, Maria
Filippiadis, Dimitris
Kelekis, Nikolaos
Zavridis, Periklis
Brountzos, Elias
Konstantos, Chrysostomos

info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

2019-02-28


Colorectal cancer is a leading cause of death both in Europe and worldwide. Unfortunately, 20-25% of patients with colorectal cancer already have metastases at the time of diagnosis, while 50-60% of the remainder will develop metastases later during the course of the disease. Although hepatic excision is the first-line treatment for patients with liver-limited colorectal metastases and is reported to prolong the survival of these patients, few patients are candidates. Locoregional therapy encompasses minimally invasive techniques practiced by interventional radiology. Most widely used locoregional therapies include ablative treatments (radiofrequency ablation, microwave ablation) and transcatheter intra-arterial therapies (transarterial chemoembolization,and radioembolization with yttrium-90). Keywords Colorectal cancer, treatment, thermal ablation, intra-arterial therapies Ann Gastroenterol 2019; 32 (2): 147-155 (EN)


English

Hellenic Society of Gastroenterology (EN)


1792-7463
1108-7471
Annals of Gastroenterology; Volume 32, No 2 (2019); 147 (EN)

Copyright (c) 2019 Annals of Gastroenterology (EN)




*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)